Search Results for

The world deserves to know exactly who is responsible for the United States not yet supporting a waiver for intellectual property rights on COVID-19 vaccine production.

As pressure mounts on the United States government to support waiving intellectual property (IP) protections on the COVID-19 vaccines at the World Trade Organization, progressives are closely monitoring the Biden administration’s appointments to agencies that impact intellectual property matters such as the United States Patent and Trademark Office (USPTO).

As the Biden administration continues to tackle the Covid-19 pandemic, Commerce Secretary Gina Raimondo holds one of the most critical but under-appreciated roles for ensuring vaccine distribution. Indeed, the Commerce Secretary is a key player determining more generally whether America and the planet prioritize Big Pharma’s wealth or public health.

As the United States approaches a full year of COVID-19-induced lockdowns, the Revolving Door Project and the Center for Economic and Policy Research called on the White House’s COVID-19 task force director Jeffrey Zients to demand that Pfizer, Moderna, and other American pharmaceutical firms open-source their COVID-19 vaccines.